Macrolide Therapy

Macrolide Therapy is a form of antibacterial therapy that utilizes macrolide antibiotics—bacteriostatic agents that inhibit protein synthesis by binding to the 50S ribosomal subunit—to target gram-positive and atypical pathogens, distinguished by its unique polyketide lactone ring structure and favorable intracellular penetration.

1K

Publications

63.1K

Citations

5.2K

Authors

1.5K

Institutions

Publications per year

2017–2026

165

Authors

5.2K

  1. WK
    Won‐Jung Koh

    Samsung Medical Center, South Korea

    11 publications · 715 citations

    11

    h-index

  2. HM
    Hiroshi Mukae

    Nagasaki University, Japan

    10 publications · 367 citations

    10

    h-index

  3. PF
    Prabhavathi Fernandes

    Cempra Pharmaceuticals (United States), United States

    10 publications · 790 citations

    10

    h-index

  4. PC
    Peter C. Appelbaum

    Penn State Milton S. Hershey Medical Center, United States

    11 publications · 701 citations

    10

    h-index

  5. JK
    Jun‐ichi Kadota

    Oita University, Japan

    9 publications · 249 citations

    9

    h-index

1–5 of 5.2K

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 116 publications · 9.3K citations

    56

    h-index

  2. Journal of Antimicrobial Chemotherapy

    JAC · 49 publications · 2.7K citations

    31

    h-index

  3. PubMed

    Repository · 72 publications · 2.7K citations

    29

    h-index

  4. The Journal of Antibiotics

    40 publications · 1.1K citations

    20

    h-index

  5. Clinical Infectious Diseases

    CID · 21 publications · 2K citations

    18

    h-index

1–5